Thus, ERK1/2 signalling operates within a strict sweet spot or fitness threshold43 to drive tumour cell proliferation with extremes of ERK1/2 signalling being associated with quiescence (low p-ERK1/2) or cell cycle arrest/senescence/death (high p-ERK1/2). This evidence concerns the gene MAPK3 and neoplasm.